Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $116 | $14,683 | $17,093 | $15,024 |
| % Growth | -99.2% | -14.1% | 13.8% | – |
| Cost of Goods Sold | $66 | $8,059 | $12,076 | $8,232 |
| Gross Profit | $50 | $6,624 | $5,017 | $6,792 |
| % Margin | 42.8% | 45.1% | 29.4% | 45.2% |
| R&D Expenses | $9 | $677 | $628 | $833 |
| G&A Expenses | $0 | $3,763 | $1,340 | $3,887 |
| SG&A Expenses | $30 | $4,243 | $2,049 | $4,440 |
| Sales & Mktg Exp. | $0 | $480 | $709 | $553 |
| Other Operating Expenses | $0 | $0 | $203 | $0 |
| Operating Expenses | $40 | $4,920 | $2,880 | $5,273 |
| Operating Income | $10 | $1,704 | $2,137 | $1,519 |
| % Margin | 8.7% | 11.6% | 12.5% | 10.1% |
| Other Income/Exp. Net | $1 | $149 | -$81 | $173 |
| Pre-Tax Income | $11 | $1,853 | $2,056 | $1,692 |
| Tax Expense | $3 | $462 | $539 | $388 |
| Net Income | $8 | $1,391 | $1,517 | $1,304 |
| % Margin | 7.2% | 9.5% | 8.9% | 8.7% |
| EPS | 0.3 | 49.48 | 53.97 | 46.39 |
| % Growth | -99.4% | -8.3% | 16.3% | – |
| EPS Diluted | 0.3 | 49.48 | 53.97 | 46.39 |
| Weighted Avg Shares Out | 28 | 28 | 28 | 28 |
| Weighted Avg Shares Out Dil | 28 | 28 | 28 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $113 | $107 | $93 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $102 | $102 | $99 |
| EBITDA | $12 | $1,806 | $2,240 | $1,790 |
| % Margin | 10.2% | 12.3% | 13.1% | 11.9% |